Shanghai Abelzeta Ltd.

This early-phase trial is testing a new treatment called A-CAR032 for men with a type of advanced prostate cancer that no longer responds to hormone therapy. The treatment involves taking a patient's own immune cells, modifying them in a lab to better recognize and attack cancer …

This early-stage trial tests a new treatment called C-CAR031 for people with advanced squamous cell lung cancer that has stopped responding to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to better recognize and attack cancer cells. The m…

This study tests a new treatment called C-CAR031 for adults with advanced or recurrent liver cancer that has not responded to at least two prior therapies. C-CAR031 is made from a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells.…

This study tests a new treatment called C-CAR039 (Prizlon-cel) for people with large B-cell lymphoma that has come back or not responded to other treatments. The therapy uses a patient's own immune cells, modified to attack two targets on cancer cells. The goal is to find the saf…